Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. J of Skin. 2025;9(6):s630. doi:10.25251/ej4zcr36